Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19

BACKGROUND: Soluble suppressor of tumorigenicity-2 (sST2) is a biomarker for heart failure and pulmonary injury. We hypothesize that sST2 could help predict severity of SARS-CoV-2 infections. METHODS: sST2 was analyzed in patients consecutively admitted for SARS-CoV-2 pneumonia. Other prognostic mar...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnaldos-Carrillo, María, Noguera-Velasco, José Antonio, Martínez-Ardil, Isabel M., Riquelme-Pérez, Alejandro, Cebreiros-López, Iria, Hernández-Vicente, Álvaro, Ros-Lucas, José Antonio, Khan, Amjad, Bayes-Genís, Antoni, Pascual-Figal, Domingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086099/
https://www.ncbi.nlm.nih.gov/pubmed/37137804
http://dx.doi.org/10.1016/j.medcli.2023.04.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086099/
https://www.ncbi.nlm.nih.gov/pubmed/37137804
http://dx.doi.org/10.1016/j.medcli.2023.04.005

Ejemplares similares